O'Grady A - Search Results

1

Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer.

Krzyzanowska A, Barron S, Higgins DF, Loughman T, O'Neill A, Sheehan KM, Wang CA, Fender B, McGuire L, Fay J, O'Grady A, O'Leary D, Watson RW, Bjartell A, Gallagher WM. Krzyzanowska A, et al. Eur Urol Focus. 2023 Nov;9(6):983-991. doi: 10.1016/j.euf.2023.04.004. Epub 2023 Apr 25. Eur Urol Focus. 2023. PMID: 37105783 Free article.

2

Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors.

Lynch SM, Russell NM, Barron S, Wang CA, Loughman T, Dynoodt P, Fender B, Lopez-Ruiz C, O'Grady A, Sheehan KM, Fay J, Amberger-Murphy V, Saha A, Klinger R, Gonzalez CA, Al-Attar N, Rahman A, O'Leary D, Lanigan FT, Bracken AP, Crown J, Kelly CM, O'Connor DP, Gallagher WM. Lynch SM, et al. Eur J Cancer. 2021 Jul;152:78-89. doi: 10.1016/j.ejca.2021.04.016. Epub 2021 Jun 2. Eur J Cancer. 2021. PMID: 34090143 Free article.

3

Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer.

Loughman T, Barron S, Wang CA, Dynoodt P, Fender B, Lopez-Ruiz C, Stapleton S, Fabre A, Quinn C, Nodin B, Jirström K, Razmara F, O'Grady A, Baird AM, Gray SG, Freixo A, Moelans CB, van Diest PJ, Duffy MJ, O'Leary D, Crown J, Bracken AP, Gallagher WM. Loughman T, et al. Clin Chem. 2022 Jun 1;68(6):837-847. doi: 10.1093/clinchem/hvac028. Clin Chem. 2022. PMID: 35312747

4

The analysis of serum response factor expression in bone and soft tissue prostate cancer metastases.

O'Hurley G, Prencipe M, Lundon D, O'Neill A, Boyce S, O'Grady A, Gallagher WM, Morrissey C, Kay EW, Watson RW. O'Hurley G, et al. Prostate. 2014 Feb;74(3):306-13. doi: 10.1002/pros.22752. Prostate. 2014. PMID: 24249383

5

Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients.

Fitzgerald S, Sheehan KM, O'Grady A, Kenny D, O'Kennedy R, Kay EW, Kijanka GS. Fitzgerald S, et al. J Gastroenterol Hepatol. 2013 Jun;28(6):967-74. doi: 10.1111/jgh.12157. J Gastroenterol Hepatol. 2013. PMID: 23425061

6

Development of a Novel Weighted Ranking Method for Immunohistochemical Quantification of a Heterogeneously Expressed Protein in Gastro-Esophageal Cancers.

Richards CE, Sheehan KM, Kay EW, Hedner C, Borg D, Fay J, O'Grady A, Hill ADK, Jirström K, Hopkins AM. Richards CE, et al. Cancers (Basel). 2021 Mar 13;13(6):1286. doi: 10.3390/cancers13061286. Cancers (Basel). 2021. PMID: 33805812 Free PMC article.

7

Cyclooxygenase-2 expression in stromal tumors of the gastrointestinal tract.

Sheehan KM, Sabah M, Cummins RJ, O'Grady A, Murray FE, Leader MB, Kay EW. Sheehan KM, et al. Hum Pathol. 2003 Dec;34(12):1242-6. doi: 10.1016/j.humpath.2003.01.001. Hum Pathol. 2003. PMID: 14691908

8

Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment.

Fitzgerald S, Espina V, Liotta L, Sheehan KM, O'Grady A, Cummins R, O'Kennedy R, Kay EW, Kijanka GS. Fitzgerald S, et al. J Transl Med. 2018 Apr 10;16(1):89. doi: 10.1186/s12967-018-1465-z. J Transl Med. 2018. PMID: 29631612 Free PMC article.

9

Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer.

Sheehan KM, O'Donovan DG, Fitzmaurice G, O'Grady A, O'Donoghue DP, Sheahan K, Byrne MF, Conroy RM, Kay EW, Murray FE. Sheehan KM, et al. Eur J Gastroenterol Hepatol. 2003 Apr;15(4):375-80. doi: 10.1097/00042737-200304000-00007. Eur J Gastroenterol Hepatol. 2003. PMID: 12655257

10

RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Toomey S, Eustace AJ, Pritzker LB, Pritzker KP, Fay J, O'Grady A, Cummins R, Grogan L, Kennedy J, O'Connor D, Young L, Kay EW, O'Donovan N, Gallagher WM, Kalachand R, Crown J, Hennessy BT. Toomey S, et al. J Natl Cancer Inst. 2016 Jul 4;108(8):djw111. doi: 10.1093/jnci/djw111. Print 2016 Aug. J Natl Cancer Inst. 2016. PMID: 27377904 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page